Bortezomib and gemcitabine in relapsed or refractory Hodgkin's lymphoma.
Mendler JH, Kelly J, Voci S, Marquis D, Rich L, Rossi RM, Bernstein SH, Jordan CT, Liesveld J, Fisher RI, Friedberg JW.
Mendler JH, et al. Among authors: friedberg jw.
Ann Oncol. 2008 Oct;19(10):1759-64. doi: 10.1093/annonc/mdn365. Epub 2008 May 25.
Ann Oncol. 2008.
PMID: 18504251
Free PMC article.
Clinical Trial.